• Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Protalix BioTherapeutics Inc

+ Add to Watchlist

PLX:US

2.4500 USD 0.0600 2.39%

As of 20:04:03 ET on 09/16/2014.

Snapshot for Protalix BioTherapeutics Inc (PLX)

Open: 2.5000 Day's Range: 2.4000 - 2.5000 Volume: 107,690
Previous Close: 2.5100 52wk Range: 2.3500 - 5.3000 1-Yr Rtn: -46.51%

Stock Chart for PLX

No chart data available.
  • PLX:US 2.4500
  • 1D
  • 1M
  • 1Y
2.5100
Interactive PLX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PLX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3300
Est. EPS (USD) (12/2014) -0.1930
Est. PEG Ratio -
Market Cap (M USD) 250.06
Shares Outstanding (M) 102.07
30 Day Average Volume 437,548
Price/Book (mrq) -
Price/Sale (ttm) 16.7960
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PLX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PLX

Protalix BioTherapeutics Inc. is a biotechnology company that has developed plant cell culture technology and a bioreactor system.

David AviezerPresident/CEOTzvi PalashChief Operating Officer
Yoseph ShaaltielExec VP:Research & DevelopmentYossi MaimonVP/CFO/Treasurer/Secretary
More Company Profile & Key Executives for PLX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil